Marianne P. Allen

Array ( [id] => 7001006 [patent_doc_number] => 20010053762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'METHOD OF TREATING REPRODUCTIVE DISORDERS' [patent_app_type] => new [patent_app_number] => 09/272945 [patent_app_country] => US [patent_app_date] => 1999-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6994 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053762.pdf [firstpage_image] =>[orig_patent_app_number] => 09272945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404448 [patent_doc_number] => 06171806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Isolated peptide defined by SEQ ID NO: 17 and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/266294 [patent_app_country] => US [patent_app_date] => 1999-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 9301 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171806.pdf [firstpage_image] =>[orig_patent_app_number] => 266294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048590 [patent_doc_number] => 20020169106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'COMPOUNDS AND METHODS FOR INHIBITING CANCER METASTASIS' [patent_app_type] => new [patent_app_number] => 09/264516 [patent_app_country] => US [patent_app_date] => 1999-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14689 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169106.pdf [firstpage_image] =>[orig_patent_app_number] => 09264516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908151 [patent_doc_number] => 20010010918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'IMMUNOLOGICAL ASSAY FOR SPONGIFORM ENCEPHALOPATHIES' [patent_app_type] => new [patent_app_number] => 09/147761 [patent_app_country] => US [patent_app_date] => 1999-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4908 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20010010918.pdf [firstpage_image] =>[orig_patent_app_number] => 09147761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1569017 [patent_doc_number] => 06377057 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Classification of biological agents according to the spectral density signature of evoked changes in cellular electric potential' [patent_app_type] => B1 [patent_app_number] => 09/251027 [patent_app_country] => US [patent_app_date] => 1999-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10471 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/377/06377057.pdf [firstpage_image] =>[orig_patent_app_number] => 09251027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380298 [patent_doc_number] => 06551795 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics' [patent_app_type] => B1 [patent_app_number] => 09/252991 [patent_app_country] => US [patent_app_date] => 1999-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 183539 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551795.pdf [firstpage_image] =>[orig_patent_app_number] => 09252991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4417169 [patent_doc_number] => 06177105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'LYCD compositions and therapy' [patent_app_type] => 1 [patent_app_number] => 9/250890 [patent_app_country] => US [patent_app_date] => 1999-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2649 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177105.pdf [firstpage_image] =>[orig_patent_app_number] => 250890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1469480 [patent_doc_number] => 06406859 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'DNA encoding a 5-HT 1F receptor and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/246075 [patent_app_country] => US [patent_app_date] => 1999-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 9 [patent_no_of_words] => 17801 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/406/06406859.pdf [firstpage_image] =>[orig_patent_app_number] => 09246075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549383 [patent_doc_number] => 06346396 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'MurA' [patent_app_type] => B1 [patent_app_number] => 09/240936 [patent_app_country] => US [patent_app_date] => 1999-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13107 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346396.pdf [firstpage_image] =>[orig_patent_app_number] => 09240936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280652 [patent_doc_number] => 20020107643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'PROCESS FOR PAN-GENOMIC DETERMINATION OF MACROMOLECULAR ATOMIC STRUCTURES' [patent_app_type] => new [patent_app_number] => 09/235986 [patent_app_country] => US [patent_app_date] => 1999-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7213 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107643.pdf [firstpage_image] =>[orig_patent_app_number] => 09235986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5858898 [patent_doc_number] => 20020123044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'METHODS FOR DIAGNOSING AND EVALUATING CANCER' [patent_app_type] => new [patent_app_number] => 09/234395 [patent_app_country] => US [patent_app_date] => 1999-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13265 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123044.pdf [firstpage_image] =>[orig_patent_app_number] => 09234395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1280315 [patent_doc_number] => 06642006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Transforming growth factor alpha hii' [patent_app_type] => B2 [patent_app_number] => 09/227853 [patent_app_country] => US [patent_app_date] => 1999-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14455 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642006.pdf [firstpage_image] =>[orig_patent_app_number] => 09227853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1384126 [patent_doc_number] => 06548261 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Alzheimer model for drug screening' [patent_app_type] => B1 [patent_app_number] => 09/223588 [patent_app_country] => US [patent_app_date] => 1998-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4902 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548261.pdf [firstpage_image] =>[orig_patent_app_number] => 09223588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477602 [patent_doc_number] => 06451556 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'EF-Tu' [patent_app_type] => B1 [patent_app_number] => 09/218197 [patent_app_country] => US [patent_app_date] => 1998-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13506 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451556.pdf [firstpage_image] =>[orig_patent_app_number] => 09218197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093163 [patent_doc_number] => 06096520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Brain glycogen phosphorylase cancer antigen' [patent_app_type] => 1 [patent_app_number] => 9/215966 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 15080 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096520.pdf [firstpage_image] =>[orig_patent_app_number] => 215966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 760968 [patent_doc_number] => 07020563 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-28 [patent_title] => 'Method of designing agonists and antagonists to IGF receptor' [patent_app_type] => utility [patent_app_number] => 09/555275 [patent_app_country] => US [patent_app_date] => 1998-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 65 [patent_no_of_words] => 18578 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/020/07020563.pdf [firstpage_image] =>[orig_patent_app_number] => 09555275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311509 [patent_doc_number] => 06613740 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Activity dependent neurotrophic factor III (ADNF III)' [patent_app_type] => B1 [patent_app_number] => 09/187330 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 51704 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613740.pdf [firstpage_image] =>[orig_patent_app_number] => 09187330 [rel_patent_id] =>[rel_patent_doc_number] =>)